Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Cancer Immunology
| Cancer Immunology |
| Autore | Subramanian Subree |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (316 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
adaptive immunity
anti-CD20 antibody anti-CTLA-4 anti-PD-1 antibody-dependent cellular cytotoxicity (ADCC) antigen presenting cells antigen-presenting cells Atypical Chemokine Receptor 4 (ACKR4) B cell aplasia BAP1 BiFab bispecific antibody cancer cancer stem cells (CSCs) cancer vaccine CAR T carcinoma CD19-CAR-T CD28 cell therapy chemo-enzymatic approach chemotherapy classical and endemic Kaposi Sarcoma colon cancer colorectal cancer combination immunotherapy CTLA-4 cytotoxicity dendritic cells differentiation DNA methylation epidemiologic studies Fab IDO inhibitor IFN-γ IL-7 IL15 immune checkpoint blockade immune checkpoint inhibitors immune checkpoints immune evasion immunomodulation immunosuppression immunotherapy indoleamine 2,3 dioxygenase 1 inhibitory CAR innate immunity interferon KIR kynurenine pathway m6A melanoma MICA/B mAb multi-state modelling n/a NK cells NKG2D organ transplantation osteoclasts PD-1 PD-L1 primary liver cancer prostate cancer resistance RNA methylation S-adenosylmethionine (SAM) sortase A systemic treatment T cells T-cell priming TCR diversity TIL treatment free interval Treg cells triple negative breast cancer tryptophan 2,3 dioxygenase 2 tumor microenvironment tumor-infiltrating lymphocytes uveal |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557349203321 |
Subramanian Subree
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Malignant Mesothelioma
| Malignant Mesothelioma |
| Autore | L. Pouliquen Daniel |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (328 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
asbestos
asbestos exposure BAP1 biomarkers cancer biomarkers cancer-specific mutations cancers carbon nanotubes carcinogenesis CDKN2A circulating tumor DNA dendritic cells DNA damage response DNA methylation DNA sequencing drug repurposing epigenome-wide analysis epithelioid extrapleural pneumonectomy fatty acid-binding protein FDG first line gene expression genomics Hippo pathway histotype immune therapy immunogenicity immunohistochemistry immunotherapy infiltrating immune cells inflammation interaction analysis laminin subunit beta-2 liquid biopsies lurbinectedin lymphocyte-to-monocyte ratio macrophage-capping protein malignant mesothelioma malignant pleural mesothelioma mesothelioma mesothelium meta-analysis metabolomics MPM MTAP mutation n/a network analysis NF2 oxidative stress PET-CT plasma pleural effusion pleural mesothelioma pleurectomy decortication predictive biomarker prognostic biomarker protein-protein interactions proteomics PTCH1 radiotherapy redox-sensitive factors sarcomatoid selenium-binding protein 1 SETD2 survival survival analysis systematic review systems biology targeted therapy therapy response tumor microenvironment tumor suppressor tumor-associated macrophages VATS WDPM well-differentiated papillary mesothelioma |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557359303321 |
|
L. Pouliquen Daniel
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||